-
1
-
-
2342616739
-
Incidence of Chemotherapy-Induced Nausea and Emesis after Modern Antiemetics: Perception versus Reality
-
DOI 10.1002/cncr.20230
-
SM Grunberg, et al. 2004 Incidence of chemotherapy-induced nausea and emesis after modern antiemetics Cancer 100 2261 2268 15139073 10.1002/cncr.20230 (Pubitemid 38580348)
-
(2004)
Cancer
, vol.100
, Issue.10
, pp. 2261-2268
-
-
Grunberg, S.M.1
Deuson, R.R.2
Mavros, P.3
Geling, O.4
Hansen, M.5
Cruciani, G.6
Daniele, B.7
De Pouvourville, G.8
Rubenstein, E.B.9
Daugaard, G.10
-
2
-
-
0031922859
-
Methodology of antiemetic trials: Response assessment, evaluation of new agents and definition of chemotherapy emetogenicity
-
DOI 10.1007/s005200050157
-
PJ Hesketh RJ Gralla AD Bois M Tonato 1998 Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity Support Care Cancer 6 221 227 9629873 10.1007/s005200050157 1:STN:280:DyaK1c3ptFyhtw%3D%3D (Pubitemid 28213056)
-
(1998)
Supportive Care in Cancer
, vol.6
, Issue.3
, pp. 221-227
-
-
Hesketh, P.J.1
Gralla, R.J.2
Du Bois, A.3
Tonato, M.4
-
3
-
-
33745515076
-
American Society of Clinical Oncology guideline for antiemetics in oncology: Update 2006
-
DOI 10.1200/JCO.2006.06.9591
-
MG Kris, et al. 2006 American society of clinical oncology guideline for antiemetics in oncology: update 2006 J Clin Oncol 24 2932 2947 16717289 10.1200/JCO.2006.06.9591 1:CAS:528:DC%2BD28XntV2gs7k%3D (Pubitemid 46630595)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.18
, pp. 2932-2947
-
-
Kris, M.G.1
Hesketh, P.J.2
Somerfield, M.R.3
Feyer, P.4
Clark-Snow, R.5
Koeller, J.M.6
Morrow, G.R.7
Chinnery, L.W.8
Chesney, M.J.9
Gralla, R.J.10
Grunberg, S.M.11
-
4
-
-
21044449000
-
ESMO minimum clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)
-
DOI 10.1093/annonc/mdi805
-
J Herrstedt MS Aapro F Roila VV Kataja 2005 ESMO minimum clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV) Ann Oncol 16 Suppl 1 i77 i79 15888767 10.1093/annonc/mdi805 (Pubitemid 40872999)
-
(2005)
Annals of Oncology
, vol.16
, Issue.SUPPL. 1
-
-
Herrstedt, J.1
Aapro, M.S.2
Roila, F.3
Kataja, V.V.4
-
5
-
-
1342267601
-
Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: A dose-ranging clinical study
-
DOI 10.1093/annonc/mdh047
-
P Eisenberg FR MacKintosh P Ritch PA Cornett A Macciocchi 2004 Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical study Ann Oncol 15 330 337 14760130 10.1093/annonc/mdh047 1:STN:280:DC%2BD2c%2FlvValtw%3D%3D (Pubitemid 38262636)
-
(2004)
Annals of Oncology
, vol.15
, Issue.2
, pp. 330-337
-
-
Eisenberg, P.1
MacKintosh, F.R.2
Ritch, P.3
Cornett, P.A.4
Macciocchi, A.5
-
6
-
-
1942476106
-
Pharmacokinetic and Safety Evaluation of Palonosetron, a 5-Hydroxytryptamine-3 Receptor Antagonist, in U.S. and Japanese Healthy Subjects
-
DOI 10.1177/0091270004264641
-
R Stoltz JC Cyong A Shah S Parisi 2004 Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in US and Japanese healthy subjects J Clin Pharmacol 44 520 531 15102873 10.1177/0091270004264641 1:CAS:528:DC%2BD2cXktlChtb0%3D (Pubitemid 38509721)
-
(2004)
Journal of Clinical Pharmacology
, vol.44
, Issue.5
, pp. 520-531
-
-
Stoltz, R.1
Cyong, J.-C.2
Shah, A.3
Parisi, S.4
-
7
-
-
10744219621
-
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: Results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron
-
DOI 10.1093/annonc/mdg417
-
R Gralla, et al. 2003 Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron Ann Oncol 14 1570 1577 14504060 10.1093/annonc/mdg417 1:STN:280:DC%2BD3svktlKitQ%3D%3D (Pubitemid 37304615)
-
(2003)
Annals of Oncology
, vol.14
, Issue.10
, pp. 1570-1577
-
-
Gralla, R.1
Lichinitser, M.2
Van Der Vegt, S.3
Sleeboom, H.4
Mezger, J.5
Peschel, C.6
Tonini, G.7
Labianca, R.8
Macciocchi, A.9
Aapro, M.10
-
8
-
-
0344412945
-
3 Receptor Antagonist: Results of a Phase III, Single-Dose Trial Versus Dolasetron
-
DOI 10.1002/cncr.11817
-
P Eisenberg, et al. 2003 Improved prevention of moderately emetogenic chemotherapy induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron Cancer 98 2473 2482 14635083 10.1002/cncr.11817 1:CAS:528:DC%2BD3sXpvFOrt70%3D (Pubitemid 37466663)
-
(2003)
Cancer
, vol.98
, Issue.11
, pp. 2473-2482
-
-
Eisenberg, P.1
Figueroa-Vadillo, J.2
Zamora, R.3
Charu, V.4
Hajdenberg, J.5
Cartmell, A.6
Macciocchi, A.7
Grunberg, S.8
-
9
-
-
33748749890
-
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
-
DOI 10.1093/annonc/mdl137
-
MS Aapro, et al. 2006 A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy Ann Oncol 17 1441 1449 16766588 10.1093/annonc/mdl137 1:STN:280:DC%2BD28rktVensw%3D%3D (Pubitemid 44400384)
-
(2006)
Annals of Oncology
, vol.17
, Issue.9
, pp. 1441-1449
-
-
Aapro, M.S.1
Grunberg, S.M.2
Manikhas, G.M.3
Olivares, G.4
Suarez, T.5
Tjulandin, S.A.6
Bertoli, L.F.7
Yunus, F.8
Morrica, B.9
Lordick, F.10
Macciocchi, A.11
-
10
-
-
58749100277
-
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: A doubleblind, double-dummy, randomised, comparative phase III trial
-
19135415 10.1016/S1470-2045(08)70313-9 1:CAS:528:DC%2BD1MXhtlGlurk%3D
-
M Saito, et al. 2009 Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a doubleblind, double-dummy, randomised, comparative phase III trial Lancet Oncol 10 115 124 19135415 10.1016/S1470-2045(08)70313-9 1:CAS:528:DC%2BD1MXhtlGlurk%3D
-
(2009)
Lancet Oncol
, vol.10
, pp. 115-124
-
-
Saito, M.1
-
11
-
-
57849152399
-
The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: A phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial
-
18825421 10.1007/s00520-008-0503-4
-
Z Yu, et al. 2009 The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial Support Care Cancer 17 99 102 18825421 10.1007/s00520-008-0503-4
-
(2009)
Support Care Cancer
, vol.17
, pp. 99-102
-
-
Yu, Z.1
-
12
-
-
0024235143
-
Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist
-
J Cassidy, et al. 1988 Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist Br J Cancer 58 651 653 2851312 10.1038/bjc.1988.278 1:STN:280:DyaL1M7hvVWhsg%3D%3D (Pubitemid 19010720)
-
(1988)
British Journal of Cancer
, vol.58
, Issue.5
, pp. 651-653
-
-
Cassidy, J.1
Raina, V.2
Lewis, C.3
Adams, L.4
Soukop, M.5
Rapeport, W.G.6
Zussman, B.D.7
Rankin, E.M.8
Kaye, S.B.9
-
13
-
-
0032992455
-
Defining the emetogenicity of cancer chemotherapy regimens: Relevance to clinical practice
-
PJ Hesketh 1999 Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice Oncologist 4 191 196 10394587 1:STN:280:DyaK1Mzit1yqsw%3D%3D (Pubitemid 29297482)
-
(1999)
Oncologist
, vol.4
, Issue.3
, pp. 191-196
-
-
Hesketh, P.J.1
-
14
-
-
0028888664
-
Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. The Italian Group for Antiemetic Research
-
The Italian Group for Antiemetic Research. 10.1056/NEJM199501053320101
-
The Italian Group for Antiemetic Research 1995 Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. The Italian Group for Antiemetic Research N Engl J Med 332 1 5 10.1056/NEJM199501053320101
-
(1995)
N Engl J Med
, vol.332
, pp. 1-5
-
-
-
15
-
-
0347816226
-
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin - The Aprepitant Protocol 052 Study Group
-
DOI 10.1200/JCO.2003.01.095
-
PJ Hesketh, et al. 2003 The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, doubleblind, placebo-controlled trial in patients receiving high-dose cisplatin-the aprepitant protocol 052 study group J Clin Oncol 21 4112 4119 14559886 10.1200/JCO.2003.01.095 1:CAS:528:DC%2BD2cXpsVajtr0%3D (Pubitemid 46606178)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.22
, pp. 4112-4119
-
-
Hesketh, P.J.1
Grunberg, S.M.2
Gralla, R.J.3
Warr, D.G.4
Roila, F.5
De Wit, R.6
Chawla, S.P.7
Carides, A.D.8
Ianus, J.9
Elmer, M.E.10
Evans, J.K.11
Beck, K.12
Reines, S.13
Horgan, K.J.14
-
16
-
-
0029033527
-
Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron study group
-
7738628 1:STN:280:DyaK2M3ls12nuw%3D%3D
-
R Navari, et al. 1995 Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron study group J Clin Oncol 13 1242 1248 7738628 1:STN:280:DyaK2M3ls12nuw%3D%3D
-
(1995)
J Clin Oncol
, vol.13
, pp. 1242-1248
-
-
Navari, R.1
-
17
-
-
44849134443
-
Chemotherapy-induced nausea and vomiting
-
DOI 10.1056/NEJMra0706547
-
PJ Hesketh 2008 Chemotherapy-induced nausea and vomiting N Engl J Med 358 2482 2494 18525044 10.1056/NEJMra0706547 1:CAS:528:DC%2BD1cXmvFKltL0%3D (Pubitemid 351793021)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.23
-
-
Hesketh, P.J.1
|